Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27522159)

Published in J Allergy Clin Immunol on August 04, 2016

Authors

Brian P Vickery1, Jelena P Berglund2, Caitlin M Burk1, Jason P Fine1, Edwin H Kim1, Jung In Kim1, Corinne A Keet3, Michael Kulis1, Kelly G Orgel1, Rishu Guo1, Pamela H Steele1, Yamini V Virkud4, Ping Ye1, Benjamin L Wright5, Robert A Wood3, A Wesley Burks6

Author Affiliations

1: University of North Carolina-Chapel Hill, Chapel Hill, NC.
2: Duke University School of Medicine, Durham, NC.
3: Johns Hopkins School of Medicine, Baltimore, Md.
4: Massachusetts General Hospital, Boston, Mass.
5: Mayo Clinic, Scottsdale, Ariz.
6: University of North Carolina-Chapel Hill, Chapel Hill, NC. Electronic address: wesley.burks@unc.edu.

Articles cited by this

Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med (2015) 12.61

Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55

Oral immunotherapy for treatment of egg allergy in children. N Engl J Med (2012) 5.19

Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet (2014) 4.36

Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol (2001) 4.31

US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol (2010) 3.99

Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91

Estimating equations for association structures. Stat Med (2004) 3.21

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77

Work Group report: oral food challenge testing. J Allergy Clin Immunol (2009) 2.66

Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol (2011) 2.13

The natural history of peanut allergy. J Allergy Clin Immunol (2001) 1.89

Early clinical predictors of remission of peanut allergy in children. J Allergy Clin Immunol (2008) 1.88

Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol (2014) 1.76

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol (2013) 1.73

Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study. J Allergy Clin Immunol (2012) 1.72

The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol (2004) 1.65

The natural progression of peanut allergy: Resolution and the possibility of recurrence. J Allergy Clin Immunol (2003) 1.49

The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol (2011) 1.45

Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort. J Allergy Clin Immunol (2007) 1.25

Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol (2010) 1.25

Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25

Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J Allergy Clin Immunol (2015) 1.10

Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol (2011) 1.08

Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy (2012) 1.08

Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol (2014) 1.07

Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment. J Allergy Clin Immunol (2015) 1.03

Comparison of open and double-blind placebo-controlled food challenges in diagnosis of food hypersensitivity amongst children. J Hum Nutr Diet (2007) 1.00

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol (2014) 0.97

Altered T-cell receptor signaling in the pathogenesis of allergic disease. J Allergy Clin Immunol (2011) 0.92

Emerging therapies for food allergy. J Clin Invest (2014) 0.83